Pilar G. A.
- Country
- Spain
- Department
- Oncology
Research Overview
- Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer
- Sotorasib and Combination Therapy Versus Standard Chemotherapy in Treatment-Naïve Patients with KRAS p.G12C-Mutated Metastatic Colorectal Cancer
- Phase 3 Randomized Double-Blind Study of INCA33890 Plus First-Line Chemotherapy and Bevacizumab in Metastatic Microsatellite Stable Colorectal Cancer
Data & Insights
Has run more than one trial at 247 of 461 partner sites.
Specializations
Gastrointestinal Oncology
This investigator specializes in clinical research focusing on therapeutic approaches for advanced colorectal cancer and metastatic colorectal cancer treatment modalities.
- Colorectal Cancer Management
- Advanced Stage Cancer Treatment
- Gastrointestinal Malignancies
The investigator explores novel therapeutic strategies including targeted monotherapy approaches for patients with advanced disease states.
Targeted Therapy Research
The investigator conducts studies in targeted cancer therapeutics, with particular emphasis on evaluating novel monoclonal antibody treatments in gastrointestinal cancers.
- Monoclonal Antibody Therapy
- Combination Treatment Strategies
- Drug Safety Assessment
Their research encompasses evaluation of innovative therapeutic agents in combination with standard-of-care chemotherapy protocols.
Clinical Trial Development
The investigator focuses on early-phase clinical trials and the development of treatment protocols for advanced cancer patients.
- Treatment Protocol Development
- Therapeutic Dose Optimization
- Anti-tumor Activity Assessment
Their work includes evaluating treatment efficacy and establishing optimal dosing strategies for novel therapeutic combinations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.